









Markets
/
Stocks
/
nasdaq-mdt
/

Medtronic PLC

MDT

90.970USD

-0.760-0.83%

Close 10/30, 16:00（ET）Quotes delayed by 15 min

116.61BMarket Cap

25.02P/E TTM



Medtronic PLC

90.970

-0.760-0.83%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Medtronic PLC

Currency: USD Updated: 2025-10-30

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Medtronic PLC's Score

Industry at a Glance

Industry Ranking

47 / 210

Overall Ranking

121 / 4621

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 35 analysts

Buy

Current Rating

101.104

Target Price

+10.22%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Medtronic PLC Highlights

StrengthsRisks

Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 33.54B.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 76.98%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 76.98%.

Undervalued

The company’s latest PE is 25.05, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 1.12B shares, decreasing 1.34% quarter-over-quarter.

Held by HOTCHKIS & WILEY

Star Investor HOTCHKIS & WILEY holds 5.93M shares of this stock.

Financial Health

Currency: USD Updated: 2025-10-30

The company's current financial score is 7.26, which is lower than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 8.58B, representing a year-over-year increase of 8.38%, while its net profit experienced a year-over-year increase of 0.19%.

Score

Industry at a Glance

Previous score

7.26

Change



Financials

7.26

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.26

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.26

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.26

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.26

Key Metrics

Free cash flow

No Data

Medtronic PLC's Company Valuation

Currency: USD Updated: 2025-10-30

The company’s current valuation score is 8.45, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is 25.05, which is 29.46% below the recent high of 32.42 and 11.17% above the recent low of 22.25.

Score

Industry at a Glance

Previous score

8.45

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 47/210

No Data

Earnings Forecast

Currency: USD Updated: 2025-10-30

The company’s current earnings forecast score is 7.26, which is lower than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for Medtronic PLC is 101.00, with a high of 115.00 and a low of 81.00.

Score

Industry at a Glance

Previous score

7.26

Change

Support & Resistance

No Data

Analyst Rating

Based on 35 analysts

Buy

Current Rating

101.104

Target Price

+10.22%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

110

Total

Median

Average

Company name

Ratings

Analysts

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

Insulet Corp

PODD

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-30

The company’s current price momentum score is 6.44, which is lower than the Healthcare Equipment & Supplies industry's average of 6.55. Sideways: Currently, the stock price is trading between the resistance level at 96.66 and the support level at 87.99, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.44

Change

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(1)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-1.236

Sell

RSI(14)

32.113

Neutral

STOCH(KDJ)(9,3,3)

11.800

Sell

ATR(14)

1.685

High Vlolatility

CCI(14)

-178.608

Sell

Williams %R

95.945

Oversold

TRIX(12,20)

-0.062

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

92.746

Sell

MA10

94.137

Sell

MA20

95.407

Sell

MA50

94.364

Sell

MA100

91.971

Sell

MA200

89.787

Buy

Institutional Confidence

Currency: USD Updated: 2025-10-30

The company’s current institutional recognition score is 7.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.43. The latest institutional shareholding proportion is 87.15%, representing a quarter-over-quarter increase of 0.04%. The largest institutional shareholder is The Vanguard, holding a total of 126.32M shares, representing 9.85% of shares outstanding, with 2.14% increase in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

126.32M

+1.51%

BlackRock Institutional Trust Company, N.A.

67.84M

-1.58%

State Street Investment Management (US)

59.83M

-0.35%

Capital Research Global Investors

36.36M

-12.53%

Geode Capital Management, L.L.C.

28.23M

+1.11%

JP Morgan Asset Management

26.31M

-6.03%

MFS Investment Management

19.36M

-6.04%

Norges Bank Investment Management (NBIM)

16.44M

+12.83%

BlackRock Financial Management, Inc.

15.63M

+10.48%

Goldman Sachs & Company, Inc.

14.73M

+319.35%

Risk Assessment

Currency: USD Updated: 2025-10-30

The company’s current risk assessment score is 9.83, which is higher than the Healthcare Equipment & Supplies industry's average of 4.57. The company's beta value is 0.78. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.